Key executive leaving High Point biotech firm following disappointing trial results

The chief medical officer of VTV Therapeutics Inc., a High Point-based clinical-stage pharmaceutical company, is leaving the company to pursue other opportunities, according to  a Securities and Exchange Commission filing. The effective date of Larry Altstiel’s departure will be April 30. In connection with his departure, the company and Altstiel agreed to terminate his employment agreement, and they are continuing to discuss the terms of his separation. Prior to VTV Therapeutics (NASDAQ: VTVT),…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news